How to Increase Libido During Menopause (2026): What Actually Helps, by Cause

Why did my libido drop — and why does the cause matter so much?

Menopause hits sexual desire through several independent channels, and a treatment aimed at the wrong one fails: pain (declining estrogen thins vaginal tissue — genitourinary syndrome of menopause, or GSM — and anticipated pain suppresses desire fast); sleep and vasomotor symptoms (chronic exhaustion is a libido treatment-resistant state); mood (depression and anxiety both lower desire — and SSRIs/SNRIs, which treat them, are themselves among the most common medication causes of low libido); hormonal shifts in estrogen and testosterone; and life context (relationship dynamics, stress, body image — real factors, not consolation prizes).

A good clinician untangles these in order, usually starting with the most fixable: is sex painful? Is sleep wrecked? Did a medication change precede the drop? The chunks below follow that same order.

What causes low libido during menopause?
Usually several things at once: painful sex from vaginal tissue changes (GSM), exhaustion from hot flashes and broken sleep, mood changes, medications (SSRIs commonly), shifting estrogen and testosterone, and life context. The effective treatment depends on which drivers are yours, which is why an evaluation beats any single product.

If sex is painful or dry: what has real evidence?

This is often the most treatable driver, with a real evidence ladder:

• Over-the-counter first: regular vaginal moisturizers (used routinely, not just before sex) plus lubricants during sex — modest evidence, no prescription, and the cheapest first step.
• Low-dose vaginal estrogen — the standard prescription treatment for GSM: creams, tablets, inserts, and rings that act locally with minimal systemic absorption. Notably, the FDA’s November 2025 labeling overhaul removed the boxed warning from these low-dose vaginal products — a regulatory acknowledgment of their local, low-absorption profile.
• Prasterone (Intrarosa) — an FDA-approved nightly vaginal DHEA insert for moderate-to-severe pain with sex due to menopause.
• Ospemifene (Osphena) — an FDA-approved oral tablet for the same indication, for women who prefer a pill to a vaginal product.

Treating pain is often the libido treatment: desire built on anticipated pain doesn’t recover until the pain does. Pelvic-floor physical therapy is the additional evidence-backed option when muscle guarding has joined the picture.

What helps painful sex during menopause?
An evidence ladder: routine vaginal moisturizers plus lubricants first; then low-dose vaginal estrogen (whose boxed warning the FDA removed in its November 2025 labeling changes); and two FDA-approved alternatives — prasterone (Intrarosa), a vaginal DHEA insert, and ospemifene (Osphena), an oral tablet. Pelvic-floor PT helps when muscle guarding is involved.

Does testosterone work for menopausal low libido?

For one specific picture, yes — with caveats. The 2019 Global Consensus Position Statement, endorsed by a coalition of international medical societies, concluded testosterone has evidence for hypoactive sexual desire disorder (HSDD) in postmenopausal women — persistent low desire causing distress, after other contributors are addressed — using doses that keep blood levels in the normal premenopausal range. For everything else (energy, mood, general wellbeing), the same consensus found insufficient evidence.

The practical catches: no testosterone product is FDA-approved for women in the US, so prescribing is off-label; it’s a controlled substance, so many menopause telehealth programs don’t prescribe it (Winona and MyMenopauseRx state on their own sites that they don’t); and monitoring matters. Who does prescribe it online, at what verified price, is covered in our dedicated guide: testosterone for women online.

Is testosterone effective for low libido in menopause?
For postmenopausal women with hypoactive sexual desire disorder (low desire with distress), the 2019 global consensus of eleven medical societies found supporting evidence — at doses keeping blood levels in the normal female range. It’s off-label in the US (no FDA-approved women’s product) and not offered by many telehealth programs.

Will going on HRT bring my libido back?

Indirectly, sometimes — and it’s worth being precise about the mechanism. Systemic HRT is the most effective treatment for hot flashes and night sweats per The Menopause Society’s 2022 position statement; when those symptoms (and the sleep they destroy) are what flattened your desire, treating them can restore the conditions desire needs. Systemic estrogen also helps vaginal symptoms for many women.

What systemic HRT is not: a desire drug. If sex is comfortable, sleep is fine, and desire alone has gone missing, adding systemic estrogen isn’t the evidence-backed answer — that picture points back to the HSDD conversation (and its testosterone branch), to mood and medication review, or to the non-drug approaches below. Whether HRT fits you at all is its own decision: see how to get HRT.

Does HRT increase libido?
Indirectly for many women: by treating hot flashes, night sweats, sleep disruption, and vaginal symptoms, HRT can remove what was suppressing desire. It is not itself a desire drug — isolated low desire with comfortable sex and decent sleep points to a different evaluation (HSDD, mood, medications) rather than systemic estrogen.

What about the “female Viagra” pills I’ve seen advertised?

Check the label’s fine print: flibanserin (Addyi) — the daily pill marketed for women’s low desire — is FDA-approved only for premenopausal women with HSDD. It has never been approved for postmenopausal women, carries an alcohol interaction warning, and its effect size even in-label is modest. Any clinic prescribing it for menopause-related low desire is prescribing off-label with thinner evidence than the options above.

Also worth naming: erectile-dysfunction drugs (sildenafil et al.) treat blood flow, not desire — they are not approved for, and don’t address, low libido in women. The mechanically similar-sounding marketing is doing a lot of work there.

Is Addyi approved for menopausal women?
No — flibanserin (Addyi) is FDA-approved only for premenopausal women with hypoactive sexual desire disorder. Use in postmenopausal women is off-label, and its effect size even within the label is modest, with an alcohol interaction warning.

What helps that isn’t a prescription?

• Sex therapy and couples counseling — desire problems live partly in context (stress, resentment, routine, body image), and psychosexual therapy has evidence for improving desire and satisfaction; guidelines treat it as a first-line component, not a fallback.
• CBT — recommended by The Menopause Society’s 2023 nonhormone therapy statement for vasomotor symptoms and helpful for the mood-and-sleep tangle around them.
• Pelvic-floor physical therapy — evidence-backed when pain or muscle guarding is part of the picture.
• Scheduling honesty — not a euphemism: responsive desire (arousal arriving after things begin, rather than spontaneously before) is common and normal in long relationships and midlife; therapists treat working with it as a legitimate, evidence-informed strategy.

Can libido improve in menopause without medication?
Often, yes — sex therapy and couples counseling have evidence for desire problems, pelvic-floor PT helps when pain is involved, CBT helps the sleep-mood tangle, and understanding responsive desire (arousal after things begin) removes a common false alarm. Medication and non-drug approaches also combine well.

Which online menopause programs treat low libido — and with what?

From RangeYourself’s verified registry, these programs list libido-relevant treatment on their own sites (prices labeled, verified on the dates in the source strip — confirm at checkout):

• Midi Health — lists FDA-approved non-hormonal prescriptions for libido specifically, alongside HRT; insurance-billed (most PPO plans), self-pay $250 initial / $150 follow-up (per-visit).
• Sesame — its menopause service lists both FDA-approved GSM options above (prasterone/Intrarosa and ospemifene) among its prescribable medications; subscription from $59/mo (recurring), meds separate at your pharmacy.
• Winona — offers vaginal estrogen cream (from $89/mo, per-product subscription) and DHEA (from $27 per 3-month supply); does not prescribe testosterone, per its own site.
• Wisp — $99 one-time menopause consult; offers estradiol vaginal cream (“starting at $20”) with prescriptions to your local pharmacy.
• Joi, Hone, and Defy — the testosterone-prescribing options, covered with verified prices in the testosterone guide.

Can online clinics treat low libido in menopause?
Yes, within limits: Midi lists libido-specific non-hormonal prescriptions, Sesame lists the FDA-approved GSM treatments (Intrarosa, ospemifene), Winona and Wisp offer vaginal estrogen, and Joi/Hone/Defy prescribe off-label testosterone — per each provider’s own site, July 2026. Desire problems rooted in mood, medications, or relationship context need broader care than a subscription.